Skip to content

Medical emergency? What to do

Women on breast cancer treatment opt for injections to curb hot flashes

3-RXPublished October 25, 20053 min read

Key points

  • Apparently, given a choice, many breast cancer patients using hormone therapies such as Tamoxifen to cut the risk of recurrence, would opt for pills rather than injections.
  • If the shots promised better control of the cancer than the pills, 74.5 percent would again pick the injections.
  • For the study, Fallowfield's team interviewed 208 women with early or advanced stage breast cancer who had been diagnosed at least two years before.
  • But when presented with a hypothetical scenario in which the injection of hormone treatments produced fewer hot flashes, the responses changed, with only 27.4 percent choosing pills and 60.6 percent picking the shots.

Apparently, given a choice, many breast cancer patients using hormone therapies such as Tamoxifen to cut the risk of recurrence, would opt for pills rather than injections.

However the British study reveals that if injections reduced hot flashes, a side effect of such treatments, more than 60 percent of the women surveyed would choose the shots.

If the shots promised better control of the cancer than the pills, 74.5 percent would again pick the injections.

The study team also found that women often skipped their hormone treatments in pill form.

Lesley Fallowfield, lead author of the study and Cancer Research UK Professor of Psychosocial Oncology at Brighton & Sussex Medical School, at the University of Sussex says the message is that unless some way is found of helping women with breast cancer deal effectively with their hot flashes, and other menopausal side effects, then optimal doses of anti-cancer drugs may not be reaching the patients.

For the study, Fallowfield's team interviewed 208 women with early or advanced stage breast cancer who had been diagnosed at least two years before.

When asked which medicine form they would prefer if daily tablets or a double injection once a month were equally effective and had equal side effects, 63 percent picked pills, 24.5 percent chose injections and 12.5 percent had no preference.

But when presented with a hypothetical scenario in which the injection of hormone treatments produced fewer hot flashes, the responses changed, with only 27.4 percent choosing pills and 60.6 percent picking the shots. Another 12 percent had no preference.

However when presented with a scenario in which the shots better controlled the cancer, even more, 74.5 percent, chose the injections.

Those who picked pills in the initial scenario said they were more convenient, while some said they disliked needles.

Those who preferred shots said they were more convenient and it was easier to comply with the therapy.

But according to the researchers it was also found that taking the pills as prescribed did not always happen.

Of the women who admitted they skipped their pills, 48.7 percent said they sometimes forgot, and 13.1 percent admitted they deliberately didn't take their pills some of the time.

Dr. Patricia Ganz, director of cancer prevention and control research at the University of California, Los Angeles Jonsson Comprehensive Cancer Center, is not surprised that women sometimes missed taking the pills, she says this is quite common, even though women with breast cancer are more motivated than others to take their medication.

But the level non-adherence was a surprise to Fallowfield.

Ganz says that prescribing hormone treatment in tablet form rather than shots is standard practice, but presently there is no injection that does not cause hot flashes.

Ganz also raises the question of whether the motivation for the study, funded by pharmaceutical company AstraZeneca, the producer of Anastrozole, one of the medications prescribed for women after breast cancer, was in order to evaluate if a market exists for the development of such an injectable drug.

According to AstraZeneca spokeswoman Katie Neff the company is not presently developing such a drug.

The study is published in the current edition of the Annals of Oncology.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBreast Cancer
Cancer

Strong social ties benefit breast cancer patients

Breast cancer patients who have a strong social support system in the first year after diagnosis are less likely to die or have a recurrence of cancer, according to new research from Vanderbilt-Ingram Cancer Center…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.